Executive Director, Head of Rare Cancer @AstraZeneca @Alexion Former Professor @Harvardmed Firm to find CURE for #RareCancer #GBM #DIPG #Sarcoma
Joined September 2018
- Tweets 839
- Following 271
- Followers 807
- Likes 1,631
90 Photos and videos
May is Brain Tumor Awareness Month.
@AstraZeneca and @AlexionPharmaUS , we are committed to advancing rare oncology research—including brain tumors—where innovation can make the greatest impact on patients and families.
#BrainTumorAwareness #RareDisease #Oncology #Innovation
22
Bakhos A. Tannous, PhD retweeted
May 1
Online Now: Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunity dlvr.it/TSKVFp
1
35
68
3,401
Bakhos A. Tannous, PhD retweeted
Mar 20
We're fueling your Friday with positivity and motivation
1
1
52
Bakhos A. Tannous, PhD retweeted
Mar 19
Online Now: A photoreceptor state links aggressive brain tumors in children dlvr.it/TRbCvd
7
30
2,797
CAR T cells are laboratory-engineered immune cells that provide effective treatment for some cancers. Progress is being made towards creating these cells in vivo
go.nature.com/3NtYGY4
8
75
251
19,160
27 Nov 2025
#Thanksgiving is not only to be greatful for all the "good" in our life, but also reflect on the “bad" and recommit our energies to giving thanks and just "#giving". Happy and blessed thanksgiving to everyone who celebrates it
4
84
Bakhos A. Tannous, PhD retweeted
15 Jul 2025
Brain metastasis: From etiology to ecotypes dlvr.it/TLxJTF
1
54
138
11,214
Bakhos A. Tannous, PhD retweeted
14 Jul 2025
The role of ultra-processed food (UPF) in obesity | @NatureRevEndo —time to sound the alarm 🚨 on UPF! Nice review that focus on the biological link between UPF and Obesity nature.com/articles/s41574-0…
1
7
31
5,102
Bakhos A. Tannous, PhD retweeted
14 Jul 2025
Pan-cancer human brain metastases atlas at single-cell resolution dlvr.it/TLw4ZN
75
237
17,079
Bakhos A. Tannous, PhD retweeted
13 Jul 2025
In the latest issue! Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis dlvr.it/TLv0mQ
2
29
115
14,916
Bakhos A. Tannous, PhD retweeted
14 Jul 2025
Recent research found that #temozolomide rechallenge is a common, safe, and effective second-line option for patients with MGMT-methylated, #IDHwildtype #GBM following first-line lomustine/temozolomide therapy.
Read the full article in our latest issue: bit.ly/4497BUq
4
11
636
Policy Corner by Abdullah H. Ishaque, MD, PhD (@ahishaque), @AbdiAidid, JD, LLM, and @gelarehzadeh, MD, PhD: Lessons from the Failure of Canada’s Artificial Intelligence and Data Act nejm.ai/4ekfI3Q
#AIinMedicine
ALT Page 1 of the Policy Corner article "Lessons from the Failure of Canada’s Artificial Intelligence and Data Act"
2
8
30
3,551
Bakhos A. Tannous, PhD retweeted
11 Jul 2025
Super excited to share our newest piece out today @NatureRevCancer linking age-induced metabolic reprogramming to cancer development. nature.com/articles/s41568-0…
11
47
240
16,123
13 Jul 2025
🟡 July is #sarcomaawarenessmonth 🟡
Sarcoma is a rare and often overlooked cancer, but its impact is deeply felt by every patient and family it touches. @AstraZeneca and @AlexionPharmaUS, we are committed to transforming outcomes for patients with rare cancers like #sarcoma
1
1
91
Bakhos A. Tannous, PhD retweeted
10 Jul 2025
The more potent and bespoke immunotherapy vs cancer, the better. Today's example is a neoantigen vaccine vs melanoma
cell.com/cell/fulltext/S0092…
3
91
356
36,269
Bakhos A. Tannous, PhD retweeted
10 Jul 2025
Online Now: KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer dlvr.it/TLrhCk
32
92
5,860
12 Jul 2025
I'm happy to share that I’ve started a new position as Executive Director, Head of Rare Cancer Discovery @AstraZeneca and @AlexionPharmaUS
Looking forward to what’s ahead!
2
2
13
297
12 Jul 2025
Excited to lead efforts across discovery and clinical strategy to bring therapies for patients with rare cancers where the need is great and the impact can be life-changing. It’s an honor to join a team so dedicated to advancing science and making a real difference for patients
2
105
Bakhos A. Tannous, PhD retweeted
4 May 2025
Online now: Niche-specific therapeutic targeting of myeloid cells in the central nervous system dlvr.it/TKYNlp
1
22
96
6,814
Bakhos A. Tannous, PhD retweeted
3 May 2025
Good update of recommendation for LGG management in the era of vorssidenib. More trials in progress
@EANOassociation
@EORTC
@SapienzaRoma
@ESTRO_RT
@myESMO
5
17
786